BioNova Pharmaceuticals (Shanghai) Ltd.

Private

ShanghaiHealthcare & Life Scienceshttps://bionovapharma.com

Last Round

Series B

Extension

Nov 23, 2020

Total Funding Raised

$17M

Company Overview

BioNova Pharmaceuticals (Shanghai) Ltd. is a biotechnology company that manufactures innovative drugs designed to advance clinical treatment for cancer and life-threatening diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

antibody-drug conjugatesADCsmall moleculesoncologydrug pipelinedrug in-licensingdrug developmentclinical stage biotechhematologic oncologyChina pharma marketmenin inhibitorCD74-targeting ADCgraft-versus-host diseaseGVHDBTK inhibitorROCK2 inhibitoracute leukemiaAI-augmented drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioNova Pharmaceuticals (Shanghai) Ltd. Comps

Public and private peers based on sector, stage, and business model.

BioNova Pharmaceuticals (Shanghai) Ltd. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BioNova Pharmaceuticals (Shanghai) Ltd. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B Extension	Nov 23, 2020
Series B	Aug 1, 2020
Series A	Dec 25, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Ye Hua

Chairman & CEO

Executive Team

BioNova Pharmaceuticals (Shanghai) Ltd. Investors

Notable investors and investment history

BioNova Pharmaceuticals (Shanghai) Ltd. investors
Investor	Rounds
BioTrack Capital	Series B
Mitsui Global Investment	Series B
TF Capital	Series A
Rencent Capital	Series B Extension
OrbiMed	Series B
Medfine Capital	Series B
Lilly Asia Ventures	Series B

View all Investors

BioNova Pharmaceuticals (Shanghai) Ltd. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

BioNova Pharmaceuticals (Shanghai) Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioNova Pharmaceuticals (Shanghai) Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai

Employee Range11

Year Founded2018

Last FundingNov 23, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.